TABLE 2. Worldwide distribution of the percentage of poor
metabolizers (PMs) of debrisoquine hydroxylase (CYP2D6) and
mephenytoin hydroxylase (CYPmp)
Population
Debrisoquine
hydroxylase
Mephenytoin
Caucasians
3-9.2%
2.5-6.7%
Arabians/Egyptians
1-1.4%
?
Asian Indians
20.8%
East Asians
0-2.4%
17.4-22%
Amerindians
0-5.2%
0%
Hispanics
4.5%
4.8%
Subsaharan Africans
0-8.1%
Sans Bushman
19%
African-Americans
1.9%
18.5%
published 2000